Eric Haura

15PUBLICATIONS

136CO-AUTHORS

Molecular targetsCancer cell biologyGene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Proteins and peptides

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 04, 2026

Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

|Dec 23, 2025

Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signaling.

Qianqian Hu, Lily L Remsing Rix, Bina Desai

|Dec 12, 2025

TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.

Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis

|Oct 30, 2025

Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors.

Yaakov E Stern, Pompom Ghosh, John Peroza

|Oct 30, 2025

RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer.

Hitendra S Solanki, Harshit Shah, Denis Imbody

|Oct 07, 2025

The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram, Abdul Rafeh Naqash, Eric B Haura

Pageof 3

Frequent Collaborators

John M Koomen

Uwe Rix

Andriy Marusyk

Bina Desai

Bin Fang

Xueli Li

Andrii Monastyrskyi

Eric A Welsh

Hitendra S Solanki

Yu Chi Yang

Frequent Collaborators

John M Koomen

Uwe Rix

Andriy Marusyk

Bina Desai